CHRNA7 and inflammatory bowel disease: Notably, by immunopathological staining, we also observed that the expression level of α7nAChR was significantly increased in CD and UC patients compared with normal tissues (Fig. 1A and B), which indicated that α7nAChR-mediated CAP might participate in the pathological development of IBD.